European Archives - Page 199 of 1535 - European Medical Journal

Early Vaccine

Early Vaccine Delays Raise Risk of Missed MMR Dose

Delayed routine infant vaccinations strongly predict missed MMR doses by age 2, raising concern as post-pandemic declines coincide with rising measles cases in the USA.

Steroid Therapy Delivers Excellent Outcomes in IgG4 Cholangitis

A decade-long retrospective study shows IgG4-related cholangitis responds well to steroids, with low mortality and no progression to cholangiocarcinoma.

tertiary lymphoid structures

Tertiary Lymphoid Structures Correlate with Immunotherapy Response in MCC

Spatial proteomics analysis shows tertiary lymphoid structures correlate with immunotherapy response and survival in Merkel cell carcinoma.

GIANT 2025 Interview: Roy Lilley

GIANT 2025 Interview: Roy Lilley. Founder and Editor-in-Chief, nhsManagers.net; Founder, The Academy of Fabulous NHS Stuff, London, UK…..

AI Improves Early Dementia Identification with EEG

New research shows EEG and AI can rapidly distinguish major dementia types.

presepsin

Plasma Presepsin Shows Promise as Mortality Predictor in Severe UTI

Plasma presepsin outperformed traditional biomarkers in predicting 28-day mortality among patients with UTI-related severe infection in emergency care.

deep sedation

Deep Sedation in ICU May Threaten Patient Independence

Medication-induced deep sedation in ICU patients is linked to loss of independence; lighter sedation and mobility improve outcomes, study finds.

imaging probe

Handheld Imaging Probe Advances Biomedical Research

The device, referred to as hPAM TUT, has a rigid body measuring 90 mm in length and just 17 mm in diameter, making it suitable for handheld use.

hormonal contraceptive

Hormonal Contraceptive Use and Heart Health: New Insights

New research links contraceptive use, mental health and differing heart risk profiles in women.

prostate cancer screening

Consultation Opens on Prostate Cancer Screening

Prostate cancer remains the most common cancer in men in the UK, with around 55,000 new cases and 12,000 deaths each year and is currently the most common cancer without a national screening programme.